Circulation (journal)
-
February 24, 2022
VUMC researchers find clue to drug-induced arrhythmias
Vanderbilt University Medical Center researchers have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms. -
February 21, 2019
AHA statement supports vascular cardio-oncology
The American Heart Association (AHA) has issued a scientific statement calling for the integration of cardio-oncology and vascular medicine to provide cancer patients and cancer survivors with optimal cardiovascular care. -
August 30, 2018
Study links aortic stiffness with lower cerebral blood flow
Greater aortic stiffness is related to lower cerebral blood flow, especially among individuals with increased genetic predisposition to Alzheimer’s disease, according to research from Vanderbilt University Medical Center. -
May 3, 2018
Gene study spots clues to heart risk for statin patients
A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol. -
April 5, 2018
Report calls for greater awareness of rare cardiac disease
A national effort seeks to raise awareness about an uncommon cause of heart attacks in otherwise healthy, young and middle-aged women. -
May 17, 2016
Study finds menthol cigarettes do not further increase smokers’ cardiovascular disease, stroke risk
Smoking is deleterious to health, but smokers who prefer menthol cigarettes to nonmenthol can breathe a sigh of relief…for now. -
February 4, 2016
Prostate cancer survivors’ risk of heart disease studied
The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.